PUBLISHER: Allied Market Research | PRODUCT CODE: 1239490
PUBLISHER: Allied Market Research | PRODUCT CODE: 1239490
The global ureteroscopy market was valued at $807.34 million in 2021, and is projected to reach $1,379.82 million by 2031, registering a CAGR of 5.5% from 2022 to 2031.
Ureteroscopy is a procedure used to diagnose and treat a wide range of urinary tract issues. A tiny scope (like flexible telescope) is introduced into the bladder and ureter. Ureteroscopy is an examination of the upper urinary tract and performed with an ureteroscope which is inserted directly into the ureter after passing through the urethra and bladder. This procedure is useful in the diagnosis and treatment of disorders such as kidney stones and urothelial carcinoma of the upper urinary tract. The procedure typically takes one to three hours to complete and is usually done while the patient is under general anesthesia.
The growth of the global ureteroscopy market is majorly driven by rise in technological advancement and increase in prevalence of urological diseases such as kidney cancer and kidney stone that require ureteroscopy devices and are the major factors that boost the market growth. Furthermore, increased medical demands in the developing countries such as India and China and growth opportunities in emerging markets are expected to create immense opportunities for the ureteroscopy market during the forecast period.
However, the high cost associated with the ureteroscopes hinders the growth of the market. Moreover, clinical barriers for ureteroscopes and risk of infection act as major restraints for the global ureteroscopy market. Conversely, increase in healthcare expenditure and rise in number of specialized hospitals & clinics in countries such as China and India are expected to create lucrative opportunities for the growth of the market.
The global ureteroscopy market is segmented into product, application, end user, and region. By product, the market is categorized into flexible ureteroscope and semi-rigid ureteroscope. On the basis of application, the market is segregated into urolithiasis, kidney cancer, urinary stricture, and others. According to end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global ureteroscopy market are: Advin Health Care, Boston Scientific Corporation, Cliniva Healthcare, Hoya Corporation, KARL STORZ SE & Co. KG, Olympus Corporation, OTU Medical, Richard Wolf GmbH, STERIS plc, and Stryker Corporation.